Bio Path | BPTH - Operating Expenses

Stock Price
0.07
Daily Change
-0.004 -5.11%
Monthly
12.72%
Yearly
-63.27%
Q1 Forecast
0.07

Bio Path reported $3.24M in Operating Expenses for its fiscal quarter ending in March of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Baxter International USD 3.19B 554.4M Dec/2025
Bio Path USD 3.24M 616K Mar/2025
Cipla INR 60.98B 1.06B Dec/2025
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 9.78M 90K Sep/2025
CSL USD 5.7B 2.82B Dec/2025
Grifols EUR 1.77B 22.04M Sep/2025
Karyopharm Therapeutics USD 61.82M 3.24M Dec/2024